76352-13-1|Tropapride|Benzamide, 2,3-dimethoxy-N-((3-exo)-8-(phenylmethyl)-8-azabicyclo(3.2.1)oct-3-yl)-|-范德生物科技公司

Tropapride

NMR下载 COA and HPLC MSDS下载
names：
Benzamide, 2,3-dimethoxy-N-((3-exo)-8-(phenylmethyl)-8-azabicyclo(3.2.1)oct-3-yl)-
CAS号：
76352-13-1
MDL Number：
MF(分子式)： C23H28N2O3 MW(分子量)： 380.488
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Benzamide, 2,3-dimethoxy-N-((3-exo)-8-(phenylmethyl)-8-azabicyclo(3.2.1)oct-3-yl)-
英文别名	Tropapride
CAS号	76352-13-1
Inchi	InChI=1S/C23H28N2O3/c1-27-21-10-6-9-20(22(21)28-2)23(26)24-17-13-18-11-12-19(14-17)25(18)15-16-7-4-3-5-8-16/h3-10,17-19H,11-15H2,1-2H3,(H,24,26)
InchiKey	PCIWCYUKRZFCMF-UHFFFAOYSA-N
分子式 Formula	C23H28N2O3
分子量 Molecular Weight	380.488
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Tropapride(CAS:76352-13-1):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Tropapride is a benzamide derivative.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Strolin Benedetti M, Dow J, Dostert S, Parisy D, Rumigny JF. Localization of a new benzamide derivative, tropapride and of 1-sulpiride, in the pituitary gland of the rat. J Pharmacol. 1984 Oct-Dec;15(4):433-8. PubMed PMID: 6543239.

[2]Collin S, Vercauteren DP, Vanderveken D, Evrard G, Durant F. Structural requirements of Na+-dependent antidopaminergic agents: Tropapride, Piquindone, Zetidoline, and Metoclopramide. Comparison with Na+-independent ligands. J Comput Aided Mol Des. 1989 Mar;3(1):39-53. PubMed PMID: 2715795.

[3] Damhaut P, Cantineau R, Lemaire C, Plenevaux A, Christiaens L, Guillaume M. 2- and 4-[18F]fluorotropapride, two specific D2 receptor ligands for positron emission tomography: N.C.A. syntheses and animal studies. Int J Rad Appl Instrum A. 1992 Oct;43(10):1265-74. PubMed PMID: 1330979.

[4] Rumigny JF, Strolin Benedetti M, Dostert P. Investigation on central dopaminergic receptors (D-2) using the antagonistic properties of new benzamides. J Pharm Pharmacol. 1984 Jun;36(6):373-7. PubMed PMID: 6146667.

[5] Wurch T, Boutet-Robinet EA, Palmier C, Colpaert FC, Pauwels PJ. Constitutive coupling of a chimeric dopamine D2/alpha 1B receptor to the phospholipase C pathway: inverse agonism to silent antagonism by neuroleptic drugs. J Pharmacol Exp Ther. 2003 Jan;304(1):380-90. PubMed PMID: 12490615.

6: Prinssen EP, Kleven MS, Koek W. Interactions between neuroleptics and 5-HT(1A) ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects. Psychopharmacology (Berl). 1999 May;144(1):20-9. PubMed PMID: 10379620.7: Pauwels PJ, Koek W. Atypical kinetics for a series of putative dopamine antagonists to reverse the low-magnitude Ca2+ phase in the dopamine-bound D2short receptor state. Naunyn Schmiedebergs Arch Pharmacol. 2002 Jan;365(1):82-5. Epub 2001 Oct 31. PubMed PMID: 11862337.8: Jalfre M, Bucher B, Dorme N, Mocquet G, Porsolt RD. Neuropharmacological profile of MD 790501, a new benzamide derivative. Arch Int Pharmacodyn Ther. 1983 Aug;264(2):232-56. PubMed PMID: 6139097.9: Pauwels PJ, Finana F, Tardif S, Wurch T, Colpaert FC. Dynamic dopamine-antagonist interactions at recombinant human dopamine D(2short) receptor: dopamine-bound versus antagonist-bound receptor states. J Pharmacol Exp Ther. 2001 Apr;297(1):133-40. PubMed PMID: 11259537.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开